Core Laboratories (NYSE:CLB) has been given a $110.00 price target by stock analysts at Royal Bank of Canada in a research report issued on Thursday. The firm presently has a “buy” rating on the oil and gas company’s stock. Royal Bank of Canada’s price target indicates a potential upside of 2.00% from the company’s current price.
CLB has been the subject of several other research reports. Deutsche Bank initiated coverage on Core Laboratories in a report on Tuesday, October 10th. They issued a “buy” rating and a $109.00 price objective for the company. Zacks Investment Research lowered Core Laboratories from a “hold” rating to a “sell” rating in a report on Tuesday, October 17th. Scotiabank set a $136.00 price objective on Core Laboratories and gave the stock a “hold” rating in a report on Wednesday, October 25th. ABN Amro raised Core Laboratories from a “hold” rating to a “buy” rating in a report on Wednesday, October 25th. Finally, ValuEngine lowered Core Laboratories from a “hold” rating to a “sell” rating in a report on Friday, September 1st. Three research analysts have rated the stock with a sell rating, six have given a hold rating and six have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $110.20.
Shares of Core Laboratories (NYSE:CLB) traded up $4.25 on Thursday, hitting $107.84. The company had a trading volume of 581,000 shares, compared to its average volume of 570,541. The company has a quick ratio of 1.81, a current ratio of 2.18 and a debt-to-equity ratio of 1.53. Core Laboratories has a one year low of $86.55 and a one year high of $125.83. The company has a market capitalization of $4,573.23, a price-to-earnings ratio of 56.61 and a beta of 1.56.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Janus Henderson Group PLC lifted its position in Core Laboratories by 1.3% during the second quarter. Janus Henderson Group PLC now owns 5,002 shares of the oil and gas company’s stock valued at $506,000 after purchasing an additional 64 shares in the last quarter. ProShare Advisors LLC lifted its position in Core Laboratories by 2.3% during the second quarter. ProShare Advisors LLC now owns 3,889 shares of the oil and gas company’s stock valued at $394,000 after purchasing an additional 87 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Core Laboratories by 0.9% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,977 shares of the oil and gas company’s stock valued at $1,112,000 after purchasing an additional 98 shares in the last quarter. Parallel Advisors LLC lifted its position in shares of Core Laboratories by 13.1% in the second quarter. Parallel Advisors LLC now owns 1,008 shares of the oil and gas company’s stock valued at $101,000 after acquiring an additional 117 shares in the last quarter. Finally, Monroe Bank & Trust MI lifted its position in shares of Core Laboratories by 1.4% in the second quarter. Monroe Bank & Trust MI now owns 9,185 shares of the oil and gas company’s stock valued at $930,000 after acquiring an additional 130 shares in the last quarter.
About Core Laboratories
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
